Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500104692Phase 3Not yet recruiting
Phase 3 trial of hyaluronic acid (2 arms), sponsored by Chongqing Xingrong Plastic Surgery Hospital. Primary endpoint: Effectiveness rate of correcting cervical transverse lines at 3 months after last injection. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500104692.